With FDA nod, AstraZeneca's FluMist becomes first self-administered flu vaccine
AstraZeneca has just scored big on the quest to make routine vaccinations less of a hassle. | The FDA signed off on AstraZeneca's influenza vaccine FluMist for self-administration by adults up to 49 years old and for administration by a parent or caregiver in kids between the ages of 2 and 17.
AstraZeneca's FluMist influenza vaccine, which can be self-administered. Experts hope an option for at-home flu vaccination ...
Iskra Reic, Executive Vice President, Vaccines and Immune Therapies, AstraZeneca, said: “The approval of FLUMIST for self-administration is an important step forward in making vaccines more ...
AstraZeneca, which makes the FluMist nasal-spray vaccine, told me that it was “engaging with the appropriate regulatory ...
He said the trivalent version of LAIV had much higher VE in children ... and viral interference by adding a second influenza B strain were all considered. AstraZeneca, the maker of FluMist, has ...
AstraZeneca’s existing Speke site is used to make a nasal flu vaccine called FluMist. AstraZeneca said: “We are committed to pursuing the opportunity at Speke and are in constructive ...
The FDA has started a review of an extension to the labelling for AstraZeneca’s influenza vaccine FluMist Quadrivalent which would allow it to be administered by patients themselves or a caregiver ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback